Prothena logo

Prothena

PRTA | NASDAQ
Chart Builder DCF Calculator
$7.97
-$0.19 (-2.33%)
At close: Nov 16, 2026, 4:00 PM ET
$7.97
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.33%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
39.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #543/1021 (Top 53%)

Key Statistics

Market Data

Market Cap $409.26M
1D Range
7.86 8.18
52W Range
7.86 11.51

Valuation (TTM)

PE -16.60
PB 1.52
EV/EBITDA -5.62

Valuation (NTM)

Forward PE 320.16
Forward PEG 0.17
Price Target $30.00
Loading financial charts...

Profile

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline i...

Sector Healthcare
Industry Biotechnology
Employees 67
IPO Date Dec 20, 2012
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.32
Miss -40.88%
REV
$620K
Miss -93.53%
Next Earnings
Feb 18, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$30.00
Upside
+276.41%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.